Seeking Alpha·3d ago
LivaNova PLC (LIVN) Q3 2026 Earnings Call TranscriptLivaNova PLC (LIVN) Q3 2026 Earnings Call Transcript
LivaNova's revenue has grown steadily from $318.6M in 2024Q2 to $393.1M in 2026Q3, with a stable gross margin near 67% that points to durable pricing in its implantable and disposable products.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Nov 4, 2026 | $1.23+16.0% vs $1.06 | $393M+3.1% vs $381M |
Q3 2026 Aug 5, 2026 | $1.26+15.6% vs $1.09 | $391M+2.7% vs $381M |
Q2 2026 May 6, 2026 | $0.98+15.3% vs $0.85 | $362M+4.7% vs $346M |
Q1 2026 Feb 25, 2026 | $0.86+7.5% vs $0.80 | $361M+2.1% vs $353M |
LivaNova PLC (LIVN) Q3 2026 Earnings Call Transcript
LivaNova NASDAQ: LIVN reported third-quarter 2026 revenue growth of 10% from the prior-year period, driven by double-digit gains in its Cardiopulmonary and epilepsy businesses. The medical technology company raised its full-year revenue and adjusted earnings outlook, citing commercial execution, healthy demand and progress in manufacturing capacity expansion.
The headline numbers for LivaNova (LIVN) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
LivaNova (LIVN) came out with quarterly earnings of $1.23 per share, beating the Zacks Consensus Estimate of $1.03 per share. This compares to earnings of $1.11 per share a year ago.
Benchmark LIVN against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for LivaNova PLC (LIVN)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $89.99 | $4.94B | 26.34 | 10.74% | 13.01% | 15.35% | — | |
| $13.28 | $1.54B | -12.74 | 8.28% | -16.78% | -35.81% | — | |
| $19.10 | $1.41B | 7.12 | 18.52% | 43.79% | 15.84% | — | |
| $224.41 | $13.24B | -80.88 | 32.33% | -24.6% | -24.91% | — | |
| $101.80 | $130.7B | 25.01 | 8.43% | 13.93% | 10.51% | 2.78% | |
| $109.93 | $191.48B | 40.64 | 5.67% | 9.75% | 9% | 2.14% |
LivaNova PLC (LIVN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
LivaNova PLC (LIVN) SEC filings — annual & quarterly reports (10-K, 10-Q)
Nov 4, 2026·SEC
Aug 5, 2026·SEC
Jun 11, 2026·SEC
Get notified when LIVN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
LivaNova PLC (LIVN) stock FAQ — growth, dividends, profitability & financials explained
LivaNova PLC (LIVN) reported $1.51B in revenue over the trailing twelve months. Revenue was $1.39B in fiscal year 2025. That is 138710% more than the $1.0M of fiscal year 1995.
LivaNova PLC (LIVN) grew revenue by 11.7% over the trailing twelve months, compared with the twelve months before.
Yes. LivaNova PLC (LIVN) earned $196.1M in net income over the trailing twelve months (a 13.0% net margin).
LivaNova PLC (LIVN) had a return on equity (ROE) of 15.4% over the trailing twelve months. That is above the market's typical 10-15%.
LivaNova PLC (LIVN) generated $129.0M in free cash flow over the trailing twelve months.
